Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome
Status:
Completed
Trial end date:
2011-09-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether a pure heart rate-lowering agent
(Ivabradine) reduces vascular inflammatory stress in patients with acute coronary syndromes